tiprankstipranks

Ra Capital discloses $16M purchase of AN2 Therapeutics common stock

RA Capital increases its stake in AN2 Therapeutics by 1.78M shares to 5.55M shares with a stock purchase of $16M. Shares of AN2 Therapeutics are up 2.3% afterhours at $14.25.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on ANTX:

Disclaimer & DisclosureReport an Issue